Novel cancer gene discovery using a forward genetic screen in RCAS-PDGFB-driven gliomas

Holger Weishaupt1, Matko Čančer1, Gabriela Rosén1

  • 1Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.

Neuro-Oncology
|June 23, 2022
PubMed
Abstract

Insights

Researchers identified a novel oncogene, PPFIBP1, in malignant gliomas using a retroviral tagging method. This discovery offers new insights into brain tumor development and potential therapeutic targets.

Area of Science:

  • Neuro-oncology
  • Genetics
  • Cancer Biology

Background:

  • Malignant gliomas are aggressive brain tumors with poor outcomes.
  • Retroviruses can induce genetic changes near their integration sites, potentially driving cancer.

Purpose of the Study:

  • To develop and utilize a high-throughput retroviral tagging system for identifying genes involved in glioma development.
  • To discover novel oncogenes and validate known cancer-related genes in malignant gliomas.

Main Methods:

  • Employed a RCAS-TVA mouse model and next-generation sequencing for retroviral integration site analysis.
  • Generated malignant stem cell lines from RCAS-PDGFB-driven glioma biopsies.
  • Integrated retroviral tagging data with clinical information.

Main Results:

  • Identified numerous common retroviral integration sites, many overlapping with known dysregulated or previously screened glioma genes.
  • Discovered novel putative cancer-causing genes, notably highlighting Ppfibp1.
  • Demonstrated that retroviral integration into the Ppfibp1 locus increases its expression, leading to shorter tumor latency.
  • Found that elevated PPFIBP1 expression in human gliomas correlates with poor prognosis and resistance to PDGF treatment.

Conclusions:

  • Established a novel forward genetics approach for identifying glioma-associated genes.
  • Validated previous findings in glioma genetics.
  • Identified PPFIBP1 as a putative oncogene in gliomagenesis with clinical relevance.